ePORE® therapy for gastrointestinal cancers delivered with the EndoVE® device can be used for the passive transmission of electrical pulses to tissue endoscopically. Cancers accessible endoscopically with the EndoVE® device include:
- Oesophageal Cancer
- Colon Cancer
- Rectal Cancer
- Gastric Cancer
ePORE® therapy can be used for a wide variety of skin cancers including:
- Local treatment of subcutaneous and cutaneous metastasis. Examples of such indications include:
- Non-melanoma skin cancers including BCC, SCC
- Metastatic melanoma
- Cutaneous metastases from other cancers eg. breast cancer
- Rarer malignancies eg. Merkel Cell Carcinoma
- Cutaneous B-cell lymphoma
- Cutaneous gynecological cancers
